• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液硫酸脑苷脂可区分正常压力脑积水和皮质下动脉硬化性脑病。

CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.

作者信息

Tullberg M, Månsson J E, Fredman P, Lekman A, Blennow K, Ekman R, Rosengren L E, Tisell M, Wikkelsø C

机构信息

Institute of Clinical Neuroscience, Sahlgren's University Hospital, University of Göteborg, Sweden.

出版信息

J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):74-81. doi: 10.1136/jnnp.69.1.74.

DOI:10.1136/jnnp.69.1.74
PMID:10864607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1737023/
Abstract

OBJECTIVES

To examine the CSF concentrations of molecules reflecting demyelination, neuronal and axonal degeneration, gliosis, monoaminergic neuronal function, and aminergic and peptidergic neurotransmission in a large series of patients with normal pressure hydrocephalus (NPH) or subcortical arteriosclerotic encephalopathy (SAE), to elucidate pathogenic, diagnostic, and prognostic features.

METHODS

CSF concentrations of glycosphingolipid (sulfatide), proteins (neurofilament triplet protein (NFL), glial fibrillary acidic protein (GFAP)), neuropeptides (vasoactive intestinal peptide (VIP), 4-aminobutyric acid (GABA)), and monoamines (homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5-HIAA), 4-hydroxy-3-methoxyphenylglycol (HMPG)) were analysed in 43 patients with NPH and 19 patients with SAE. The diagnoses of NPH and SAE were based on strict criteria and patients with NPH were subsequently operated on. Twelve clinical variables, psychometric tests measuring perceptual speed, accuracy, learning, and memory and a psychiatric evaluation were performed in all patients and before and after a shunt operation in patients with NPH.

RESULTS

The CSF sulfatide concentration was markedly increased in patients with SAE (mean 766, range 300-3800 nmol/l) compared with patients with NPH (mean 206, range 50-400 nmol/l) (p<0.001). 5-HIAA, GABA, and VIP in CSF were higher in patients with SAE than in patients with NPH. The patients with NPH with cerebrovascular aetiology had higher sulfatide concentrations and a poorer outcome after shunt surgery than patients with NPH with other aetiologies.

CONCLUSIONS

The pathogenesis of the white matter changes in NPH and SAE is different and ischaemic white matter changes can be a part of the NPH state. The markedly increased CSF sulfatide concentrations in patients with SAE indicate ongoing demyelination as an important pathophysiological feature of SAE. The CSF sulfatide concentration distinguished between patients with SAE and those with NPH with a sensitivity of 74% and a specificity of 94%, making it an important diagnostic marker.

摘要

目的

检测大量正常压力脑积水(NPH)或皮质下动脉硬化性脑病(SAE)患者脑脊液中反映脱髓鞘、神经元及轴突退变、胶质增生、单胺能神经元功能以及胺能和肽能神经传递的分子浓度,以阐明其致病、诊断及预后特征。

方法

分析43例NPH患者和19例SAE患者脑脊液中糖鞘脂(硫脂)、蛋白质(神经丝三联蛋白(NFL)、胶质纤维酸性蛋白(GFAP))、神经肽(血管活性肠肽(VIP)、γ-氨基丁酸(GABA))以及单胺(高香草酸(HVA)、5-羟吲哚乙酸(5-HIAA)、4-羟基-3-甲氧基苯乙二醇(HMPG))的浓度。NPH和SAE的诊断基于严格标准,NPH患者随后接受手术。对所有患者进行12项临床变量、测量感知速度、准确性、学习和记忆的心理测试以及精神评估,对NPH患者在分流手术前后也进行了这些评估。

结果

与NPH患者(平均206,范围50 - 400 nmol/l)相比,SAE患者脑脊液硫脂浓度显著升高(平均766,范围300 - 3800 nmol/l)(p<0.001)。SAE患者脑脊液中的5-HIAA、GABA和VIP高于NPH患者。有脑血管病因的NPH患者比其他病因的NPH患者硫脂浓度更高,分流手术后预后更差。

结论

NPH和SAE中白质改变的发病机制不同,缺血性白质改变可能是NPH状态的一部分。SAE患者脑脊液硫脂浓度显著升高表明正在进行的脱髓鞘是SAE的重要病理生理特征。脑脊液硫脂浓度区分SAE患者和NPH患者的敏感性为74%,特异性为94%,使其成为重要的诊断标志物。

相似文献

1
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.脑脊液硫酸脑苷脂可区分正常压力脑积水和皮质下动脉硬化性脑病。
J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):74-81. doi: 10.1136/jnnp.69.1.74.
2
CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.脑脊液生物标志物在特发性正常压力脑积水评估中的应用
Acta Neurol Scand. 2007 Nov;116(5):333-9. doi: 10.1111/j.1600-0404.2007.00890.x.
3
White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination.正常压力脑积水和宾斯旺格病中的白质变化:特异性、预测价值以及与轴突退变和脱髓鞘的相关性
Acta Neurol Scand. 2002 Jun;105(6):417-26. doi: 10.1034/j.1600-0404.2002.01189.x.
4
Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus.在正常压力脑积水患者进行分流手术后,脑室脑脊液神经丝蛋白水平与白质病变平行下降。
Eur J Neurol. 2007 Mar;14(3):248-54. doi: 10.1111/j.1468-1331.2006.01553.x.
5
Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha.正常压力脑积水引发鞘内肿瘤坏死因子-α的产生。
Neurobiol Aging. 2003 Sep;24(5):707-14. doi: 10.1016/s0197-4580(02)00187-2.
6
Postural disturbance in patients with normal pressure hydrocephalus.正常压力脑积水患者的姿势障碍
Acta Neurol Scand. 2000 Nov;102(5):284-91. doi: 10.1034/j.1600-0404.2000.102005284.x.
7
CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.正常压力脑积水患者脑脊液中的神经丝蛋白和胶质纤维酸性蛋白
Neurology. 1998 Apr;50(4):1122-7. doi: 10.1212/wnl.50.4.1122.
8
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia.硫酸脑苷脂作为血管性痴呆患者脑脊液中的一种生化标志物。
Acta Neurol Scand. 1992 Feb;85(2):103-6. doi: 10.1111/j.1600-0404.1992.tb04006.x.
9
Elevated CNS concentrations of NFL in idiopathic normal pressure hydrocephalus (INPH) and subcortical arteriosclerotic encephalopathy (SAE).
Acta Neurol Scand. 2008 Jun;117(6):435. doi: 10.1111/j.1600-0404.2007.00975.x. Epub 2008 Feb 28.
10
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.低脑脊髓液硫酸脑苷脂预示着白质病变的进展:LADIS 研究。
Dement Geriatr Cogn Disord. 2012;34(1):61-7. doi: 10.1159/000341576. Epub 2012 Aug 22.

引用本文的文献

1
A bibliometric analysis and visualization of normal pressure hydrocephalus.正常压力脑积水的文献计量分析与可视化
Front Neurol. 2024 Jul 31;15:1442493. doi: 10.3389/fneur.2024.1442493. eCollection 2024.
2
Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus.特发性正常压力脑积水患者的血浆和脑脊液中神经丝轻蛋白浓度相关。
Fluids Barriers CNS. 2023 Jul 6;20(1):54. doi: 10.1186/s12987-023-00455-y.
3
Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review.正常压力脑积水的脑脊液生物标志物:一篇综述
Diagnostics (Basel). 2022 Nov 28;12(12):2976. doi: 10.3390/diagnostics12122976.
4
Small Vessel Disease: Ancient Description, Novel Biomarkers.小血管疾病:古老的描述,新的生物标志物。
Int J Mol Sci. 2022 Mar 23;23(7):3508. doi: 10.3390/ijms23073508.
5
Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease.特发性正常压力脑积水和皮质下小血管病的脑脊液生物标志物共享特征
Front Neurol. 2022 Mar 3;13:839307. doi: 10.3389/fneur.2022.839307. eCollection 2022.
6
Differentiating comorbidities and predicting prognosis in idiopathic normal pressure hydrocephalus using cerebrospinal fluid biomarkers: a review.使用脑脊液生物标志物鉴别特发性正常压力脑积水的合并症并预测其预后:综述。
Croat Med J. 2021 Aug 31;62(4):387-398. doi: 10.3325/cmj.2021.62.387.
7
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis.小血管疾病对神经退行性变的影响:聚焦于阿尔茨海默病、帕金森病和多发性硬化症。
Int J Mol Sci. 2021 May 7;22(9):4958. doi: 10.3390/ijms22094958.
8
High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS.使用自动萃取和超高效液相色谱-串联质谱法对脑脊液中的硫苷脂进行高通量分析。
J Lipid Res. 2017 Jul;58(7):1482-1489. doi: 10.1194/jlr.D076588. Epub 2017 May 26.
9
Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.与皮质下小血管病相关的血管性认知障碍中的生物化学标志物——一份共识报告。
BMC Neurol. 2017 May 23;17(1):102. doi: 10.1186/s12883-017-0877-3.
10
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.用于诊断痴呆的液体生物标志物:原理和加拿大痴呆诊断和治疗共识对加拿大医生的建议。
Alzheimers Res Ther. 2013 Nov 25;5(Suppl 1):S8. doi: 10.1186/alzrt223.

本文引用的文献

1
SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE. A TREATABLE SYNDROME.具有“正常”脑脊液压力的症状性隐匿性脑积水。一种可治疗的综合征。
N Engl J Med. 1965 Jul 15;273:117-26. doi: 10.1056/NEJM196507152730301.
2
Neurofilament protein levels in CSF are increased in dementia.痴呆症患者脑脊液中的神经丝蛋白水平会升高。
Neurology. 1999 Mar 23;52(5):1090-3. doi: 10.1212/wnl.52.5.1090.
3
A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid.
Neurochem Int. 1998 Aug;33(2):103-8. doi: 10.1016/s0197-0186(98)00027-8.
4
CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.正常压力脑积水患者脑脊液中的神经丝蛋白和胶质纤维酸性蛋白
Neurology. 1998 Apr;50(4):1122-7. doi: 10.1212/wnl.50.4.1122.
5
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.一项关于85岁老年人血脑屏障功能的群体研究:与阿尔茨海默病和血管性痴呆的关系。
Neurology. 1998 Apr;50(4):966-71. doi: 10.1212/wnl.50.4.966.
6
Alterations in glia and axons in the brains of Binswanger's disease patients.宾斯旺格病患者大脑中胶质细胞和轴突的改变。
Stroke. 1997 Jul;28(7):1423-9. doi: 10.1161/01.str.28.7.1423.
7
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.克雅氏病患者脑脊液中tau蛋白水平升高。
Neurosci Lett. 1997 Apr 11;225(3):210-2. doi: 10.1016/s0304-3940(97)00215-2.
8
The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells.
Acta Neuropathol. 1997 Mar;93(3):219-24. doi: 10.1007/s004010050607.
9
Frontal brain and leptomeningeal biopsy specimens correlated with cerebrospinal fluid outflow resistance and B-wave activity in patients suspected of normal-pressure hydrocephalus.对于疑似正常压力脑积水的患者,额叶脑活检和软脑膜活检标本与脑脊液流出阻力及B波活动相关。
Neurosurgery. 1997 Mar;40(3):497-502. doi: 10.1097/00006123-199703000-00013.
10
Vascular pathology in three cases of progressive cognitive deterioration.
J Neurol Sci. 1996 Feb;135(2):131-9. doi: 10.1016/0022-510x(95)00273-5.